Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-06-27
2006-06-27
Desai, Rita (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S315000, C546S018000, C546S184000
Reexamination Certificate
active
07067525
ABSTRACT:
Compounds having the formula (I),G is a novel side chain selected from C2-6alkenyl, A3-aryl, —OR18, heteroaryl, A1-cyano, A2—OR17, A1—C(═O)R18, A1—CO2R18, A1—C(═O)NR18R19, A1—OC(═O)R18, A1—NR18C(═O)R19, A1—OC(═O)NR18R19, A1—NR18CO2R19, A1—NR18SO2R17, A1—SO2R17, A1—NR20C(═O)NR18R19, and A1—SR18; or when y is 0 or when W is not NHR22, G may be A1-heterocyclo, wherein A1is a bond, C1-6alkylene or C2-alkenylene, A2is C1-6alkylene or C2-6alkenylene, and A3is C2-6alkenylene; W is selected from —NR21R22, —OR23, —NR21C(═O)R24, —NR21CO2R24, amidino, guanidino, or a heteroaryl, heterocyclo or C3-7cycloalkyl as defined in the specification, and X and R1through R24are as defined in the specification, are effective as modulators of melanocortin-receptors, particularly MC-1R and MC-4R.
REFERENCES:
patent: 5559128 (1996-09-01), Chakravarty et al.
patent: 5804578 (1998-09-01), Chakravarty et al.
patent: 5919777 (1999-07-01), Hansen et al.
patent: WO97/83673 (1997-10-01), None
patent: WO 99/58501 (1999-11-01), None
patent: WO 99/64002 (1999-12-01), None
patent: WO 00/15657 (2000-03-01), None
patent: WO 00/44770 (2000-08-01), None
patent: WO 00/74679 (2000-12-01), None
patent: WO 01/70708 (2001-09-01), None
patent: WO 01/91752 (2001-12-01), None
patent: WO 02/00654 (2002-01-01), None
patent: WO 02/15909 (2002-02-01), None
patent: WO 02/059107 (2002-08-01), None
patent: WO 02/059108 (2002-08-01), None
Herpin Timothy
Lawrence R. Michael
Macor John
Morton George C.
Poindexter Graham S.
Bristol-Myers Squibb Co.
Desai Rita
Duncan Laurelee A.
LandOfFree
Compounds useful as modulators of Melanocortin Receptors and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds useful as modulators of Melanocortin Receptors and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds useful as modulators of Melanocortin Receptors and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3654730